News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

News

Advertisement

"On-Dose" Anticounterfeiting Vendor Looks at Stem Cell Opportunities

By
January 8th 2009

Winter Spawns Free Antibiotic Programs

By
January 8th 2009

Grocery stores fight big-box retailers by giving away generics

Advertisement

Key Account Management: A Win-Win Proposition for Pharmaceutical Companies and Their Major Customers

ByNeeraj Singhal, Cegedim Dendrite
January 5th 2009

Reorganizing a sales force into key account teams requires more planning and coordination. Access to real-time account information enhances the team effort.

Cegedim Dendrite Tailors Software for Medical Science Liaisons

ByNick Basta
January 5th 2009

The key opinion leader/MSL relationship is the target

  • Prev
  • 1
  • More pages
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • Prev
Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

BioNTech Launches Public Exchange Offer for CureVac in $1.25B All-Stock Deal

2

Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models

3

Pharma Pulse: MJH Life Sciences Expands into Health Systems, Novo Nordisk Board Shakeup Moves Markets, and Mark Cuban Grows Cost Plus Drugs Network

4

Mark Cuban Confirms Cost Plus Drugs Partnership

5

The Unsung Allies Helping Patients Navigate Specialty Drug Access

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us